Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison

National Comprehensive Cancer Network. Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate_blocks.pdf. Accessed January 17, 2021. Xia, 2010, Comparison of three strategies in management of independent movement of the prostate and pelvic lymph nodes, Med Phys, 37, 5006, 10.1118/1.3480505 Hsu, 2007, A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes, Int J Radiat Oncol, 68, 898, 10.1016/j.ijrobp.2007.02.030 Ferjani, 2013, Alignment focus of daily image guidance for concurrent treatment of prostate and pelvic lymph nodes, Int J Radiat Oncol, 87, 383, 10.1016/j.ijrobp.2013.06.003 Kishan, 2015, Pelvic nodal dosing with registration to the prostate: Implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy, Int J Radiat Oncol Biol Phys, 91, 832, 10.1016/j.ijrobp.2014.11.035 Kishan, 2019, Stereotactic body radiotherapy to the prostate and pelvic lymph nodes: A detailed dosimetric analysis of a phase II prospective trial, Br J Radiol, 92 Calais, 2018, The utility of PET/CT in the planning of external radiation therapy for prostate cancer, J Nucl Med, 59, 557, 10.2967/jnumed.117.196444 Hofman, 2020, Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): A prospective, randomised, multicentre study, Lancet, 395, 1208, 10.1016/S0140-6736(20)30314-7 Calais, 2018, Potential impact of 68Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer, J Nucl Med, 59, 1714, 10.2967/jnumed.118.209387 Levin-Epstein, 2020, Clinical assessment of prostate displacement and planning target volume margins for stereotactic body radiotherapy of prostate cancer, Front Oncol, 10, 539, 10.3389/fonc.2020.00539 Beard, 1996, Analysis of prostate and seminal vesicle motion: Implications for treatment planning, Int J Radiat Oncol Biol Phys, 34, 451, 10.1016/0360-3016(95)02081-0 Lovelock, 2015, Continuous monitoring and intrafraction target position correction during treatment improves target coverage for patients undergoing SBRT prostate therapy, Int J Radiat Oncol Biol Phys, 91, 588, 10.1016/j.ijrobp.2014.10.049 Kupelian, 2007, Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy, Int J Radiat Oncol Biol Phys, 67, 1088, 10.1016/j.ijrobp.2006.10.026 Murthy, 2018, Early results of extreme hypofractionation using stereotactic body radiation therapy for high-risk, very high-risk and node-positive prostate cancer, Clin Oncol, 30, 442, 10.1016/j.clon.2018.03.004 van Herk, 2004, Errors and margins in radiotherapy, Semin Radiat Oncol, 14, 52, 10.1053/j.semradonc.2003.10.003 Oh, 2017, Deformable image registration in radiation therapy, Radiat Oncol J, 35, 101, 10.3857/roj.2017.00325 Dang, 2018, Image-guided radiotherapy for prostate cancer, Transl Androl Urol, 7, 308, 10.21037/tau.2017.12.37 O'Neil, 2016, Fiducial marker guided prostate radiotherapy: A review, Br J Radiol, 89 Ghadjar, 2019, ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer, Radiother Oncol, 141, 5, 10.1016/j.radonc.2019.08.027 Kershaw, 2018, Image guided radiation therapy strategies for pelvic lymph node irradiation in high-risk prostate cancer: Motion and margins, Int J Radiat Oncol, 100, 68, 10.1016/j.ijrobp.2017.08.044 O'Daniel, 2006, Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy, Int J Radiat Oncol Biol Phys, 66, 883, 10.1016/j.ijrobp.2006.06.044 Thörnqvist, 2013, Degradation of target coverage due to interfraction motion during intensity-modulated proton therapy of prostate and elective targets, Acta Oncol, 52, 521, 10.3109/0284186X.2012.752860 Hinton, 2013, Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients, ISRN Oncol, 2013, 1, 10.1155/2013/941269